Related Experiment Video
Updated: Jun 15, 2026

09:00
Biochemical Purification and Proteomic Characterization of Amyloid Fibril Cores from the Brain
Published on: April 28, 2022
[Fullerenes C60, antiamyloid action, the brain and cognitive processes]
Biofizika
|February 27, 2010
Summary
Fullerenes C60 show promise in combating Alzheimer's disease by targeting amyloid proteins and improving cognitive function. This research explores their potential as a novel therapeutic strategy for early-stage disease.
Area of Science:
- Neuroscience
- Materials Science
- Pharmacology
Context:
- Alzheimer's disease (AD) is a progressive neurodegenerative disorder characterized by amyloid-beta plaque accumulation.
- Current treatments offer limited efficacy, necessitating novel therapeutic approaches.
- Fullerenes, particularly C60, are emerging as potential therapeutic agents.
Purpose:
- To review recent investigations into the antiamyloid properties of fullerenes C60.
- To discuss the potential of fullerenes in correcting cognitive deficits associated with Alzheimer's disease.
- To explore the prospects of developing fullerene-based drugs for early-stage Alzheimer's disease.
Summary:
- Fullerenes C60 exhibit significant antiamyloid activity, interfering with the key molecular mechanisms of Alzheimer's disease.
- Studies suggest that fullerenes C60 can help correct disturbed cognitive processes.
- The review highlights the potential of C60 fullerenes as a therapeutic intervention for early AD.
Impact:
- Fullerenes C60 represent a promising new class of compounds for Alzheimer's disease therapeutics.
- Targeting early molecular mechanisms offers a novel strategy for disease modification.
- Further development could lead to innovative drugs for Alzheimer's disease treatment.
Related Concept Videos
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function. They...
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Role of Cerebellum and Prefrontal Cortex in Memory
The cerebellum, while traditionally associated with motor control, also plays a crucial role in memory, particularly in procedural memory, which involves learning motor tasks that become automatic through repetition. For example, studies have shown that when the cerebellum is damaged, individuals or animals lose the ability to learn conditioned motor responses, such as the conditioned eye-blink response in classical conditioning experiments with rabbits. This study demonstrates the cerebellum's...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining, normally used to...
Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...

